The Efficacy of Moclobemide in Treatment of Major Depression
The effectiveness and the tolerence of moclobemde -one of the reversible inhibitors of MAO-A were assessed in an open clinical trial on 19 inpatients with major depression according to DSM.III and with a score of 16 or more on Hamilton Rating Scale of Depression (HRSD). As a result, a statistically...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mesut Çetin
2021-03-01
|
| סדרה: | Psychiatry and Clinical Psychopharmacology |
| נושאים: | |
| גישה מקוונת: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/106 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|